Detalhe da pesquisa
1.
Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopenia.
Blood
; 126(11): 1367-78, 2015 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26224646
2.
In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation.
Blood
; 119(17): 4066-72, 2012 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-22294727
3.
Platelet activation and inhibition in sickle cell disease (pains) study.
Platelets
; 25(1): 27-35, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-23469943
4.
Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.
Circulation
; 120(25): 2586-96, 2009 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-19996015
5.
Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity.
Platelets
; 20(7): 513-9, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19852691
6.
Effect of adenosine A2 receptor stimulation on platelet activation-aggregation: differences between canine and human models.
Thromb Res
; 121(5): 689-98, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-17727923
7.
Effects of physiologic agonists on canine whole blood flow cytometry assays of leukocyte-platelet aggregation and platelet activation.
Vet Immunol Immunopathol
; 123(3-4): 345-52, 2008 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18405981
8.
Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.
Circulation
; 113(25): 2888-96, 2006 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-16785341
9.
The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirin.
Thromb Haemost
; 98(1): 192-200, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17598013
10.
Cystic fibrosis heterozygotes do not have increased platelet activation.
Thromb Res
; 121(2): 159-62, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17532368
11.
Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization.
J Am Coll Cardiol
; 43(12): 2319-25, 2004 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-15193700
12.
Platelet activation in a population of critically ill dogs as measured with whole blood flow cytometry and thromboelastography.
Am J Vet Res
; 76(4): 328-37, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25815574
13.
Quantification of abciximab-induced platelet inhibition is assay dependent: a comparative study in patients undergoing percutaneous coronary intervention.
Am Heart J
; 145(2): e6, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12595861
14.
Combined effects of mild hypothermia and glycoprotein IIb/IIIa antagonists on platelet-platelet and leukocyte-platelet aggregation.
Am J Cardiol
; 92(9): 1099-101, 2003 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14583364
15.
Antiplatelet activity, P2Y1 and P2Y12 inhibition, and metabolism in plasma of stereoisomers of diadenosine 5',5'â³-P¹ ,P4-dithio-P²,P³-chloromethylenetetraphosphate.
PLoS One
; 9(4): e94780, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24722456
16.
P2Y12 receptor blockade augments glycoprotein IIb-IIIa antagonist inhibition of platelet activation, aggregation, and procoagulant activity.
J Am Heart Assoc
; 2(3): e000026, 2013 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23676293
17.
Clopidogrel pharmacokinetics and pharmacodynamics vary widely despite exclusion or control of polymorphisms (CYP2C19, ABCB1, PON1), noncompliance, diet, smoking, co-medications (including proton pump inhibitors), and pre-existent variability in platelet function.
J Am Coll Cardiol
; 61(8): 872-9, 2013 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-23333143
18.
Concurrent acute myeloid leukemia and T lymphoblastic lymphoma in a patient with rearranged PDGFRB genes.
Diagn Pathol
; 7: 19, 2012 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22356850
19.
The human endogenous circadian system causes greatest platelet activation during the biological morning independent of behaviors.
PLoS One
; 6(9): e24549, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21931750
20.
The influence of intermittent hypoxemia on platelet activation in obese patients with obstructive sleep apnea.
J Clin Sleep Med
; 7(2): 172-8, 2011 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21509332